Unlike KDM3A, which is mostly regarded as an oncogene [2], KDM3B is the first KDM3 to be proposed as a tumor suppressor gene in acute myeloid leukemia (AML), colorectal cancer (CRC), and breast cancer (BCa) (16-19)] (Table 1). This evidence concerns the gene KDM3B and colorectal carcinoma.